Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $23,990 - $27,200
500 New
500 $27,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $58,096 - $63,984
-800 Reduced 80.0%
200 $0
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $43,036 - $51,604
700 Added 233.33%
1,000 $5,000
Q3 2019

Nov 01, 2019

SELL
$42.77 - $50.71 $8,554 - $10,142
-200 Reduced 40.0%
300 $2,000
Q2 2019

Jul 26, 2019

SELL
$44.62 - $49.34 $40,158 - $44,406
-900 Reduced 64.29%
500 $1,000
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $22,076 - $24,900
400 Added 40.0%
1,400 $5,000
Q1 2018

Apr 18, 2018

BUY
$59.92 - $68.98 $59,920 - $68,980
1,000 New
1,000 $6,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.